A detailed history of Schroder Investment Management Group transactions in United Therapeutics Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 165,802 shares of UTHR stock, worth $60.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
165,802
Previous 226,809 26.9%
Holding current value
$60.3 Million
Previous $72.3 Million 17.76%
% of portfolio
0.06%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $19 Million - $22.2 Million
-61,007 Reduced 26.9%
165,802 $59.4 Million
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $2.44 Million - $3.41 Million
10,685 Added 4.94%
226,809 $72.3 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $5.96 Million - $7.05 Million
28,271 Added 15.05%
216,124 $49.6 Million
Q4 2023

Feb 13, 2024

BUY
$214.88 - $256.94 $2.12 Million - $2.53 Million
9,848 Added 5.53%
187,853 $41.3 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $6.67 Million - $7.82 Million
31,510 Added 21.51%
178,005 $40.2 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $462,087 - $524,693
2,252 Added 1.56%
146,495 $32.3 Million
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $24.3 Million - $31.4 Million
113,869 Added 374.89%
144,243 $32.3 Million
Q4 2022

Feb 10, 2023

SELL
$205.95 - $280.43 $5.76 Million - $7.84 Million
-27,964 Reduced 47.93%
30,374 $8.45 Million
Q3 2022

Nov 10, 2022

SELL
$203.3 - $244.17 $774,369 - $930,043
-3,809 Reduced 6.13%
58,338 $12.2 Million
Q2 2022

Aug 11, 2022

SELL
$174.81 - $241.14 $4.49 Million - $6.2 Million
-25,712 Reduced 29.27%
62,147 $14.8 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $4.32 Million - $5.56 Million
25,996 Added 42.02%
87,859 $15.4 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $189,480 - $222,130
-1,028 Reduced 1.63%
61,863 $13.4 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $769,441 - $919,256
-4,278 Reduced 6.37%
62,891 $11.6 Million
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $2.06 Million - $2.56 Million
12,073 Added 21.91%
67,169 $12.1 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $8.66 Million - $9.84 Million
-56,252 Reduced 50.52%
55,096 $9.22 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $9.92 Million - $14.8 Million
-97,366 Reduced 46.65%
111,348 $16.9 Million
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $1.36 Million - $1.65 Million
13,610 Added 6.98%
208,714 $21.3 Million
Q2 2020

Aug 13, 2020

BUY
$92.74 - $125.82 $9.17 Million - $12.4 Million
98,902 Added 102.81%
195,104 $23.6 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $7.64 Million - $11.1 Million
96,202 New
96,202 $9.21 Million
Q2 2019

Aug 08, 2019

SELL
$76.06 - $120.81 $4.23 Million - $6.71 Million
-55,559 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$107.15 - $126.84 $14 Million - $16.6 Million
-130,815 Reduced 70.19%
55,559 $6.52 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $3.88 Million - $4.92 Million
-38,250 Reduced 17.03%
186,374 $20.3 Million
Q3 2018

Nov 13, 2018

SELL
$113.81 - $129.46 $12.3 Million - $13.9 Million
-107,675 Reduced 32.4%
224,624 $28.7 Million
Q2 2018

Aug 13, 2018

SELL
$101.14 - $118.31 $4.89 Million - $5.72 Million
-48,378 Reduced 12.71%
332,299 $37 Million
Q1 2018

May 11, 2018

SELL
$107.21 - $151.94 $51.2 Million - $72.6 Million
-477,518 Reduced 55.64%
380,677 $42.8 Million
Q4 2017

Feb 09, 2018

SELL
$118.58 - $151.28 $22.6 Million - $28.8 Million
-190,684 Reduced 18.18%
858,195 $127 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $120 Million - $143 Million
1,048,879
1,048,879 $125 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.